Why Multinational Clinical Trials Are Key to Bringing Novel Therapies to Market
Dec 14, 2022 ·
27m 19s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
In the second episode, Pavle Vukojevic, a rheumatologist turned clinical researcher who is now the chief scientific officer at Allucent, explains why multinational clinical trials are key to bringing novel...
show more
In the second episode, Pavle Vukojevic, a rheumatologist turned clinical researcher who is now the chief scientific officer at Allucent, explains why multinational clinical trials are key to bringing novel therapies to market.
show less
Information
| Author | Industry Dive's studioID |
| Website | - |
| Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
